您的购物车当前为空
Ursodeoxycholic acid-d5是Ursodeoxycholic acid的氘代物。Ursodeoxycholic acid (Ursodeoxycholate) 是一种次级胆汁酸,由肠道细菌转化 (cheno)脱氧胆酸生成,是维持肠道屏障完整性的关键调节因子,对脂质代谢至关重要。此化合物作为信号分子作用,通过与包括G蛋白偶联的胆汁酸受体5 (TGR5,GPCR19) 和法尼酯X受体 (FXR) 在内的胆汁酸激活受体相互作用,可用于多种肝脏和胃肠道疾病的研究。此外,Ursodeoxycholic acid具有口服活性。

Ursodeoxycholic acid-d5是Ursodeoxycholic acid的氘代物。Ursodeoxycholic acid (Ursodeoxycholate) 是一种次级胆汁酸,由肠道细菌转化 (cheno)脱氧胆酸生成,是维持肠道屏障完整性的关键调节因子,对脂质代谢至关重要。此化合物作为信号分子作用,通过与包括G蛋白偶联的胆汁酸受体5 (TGR5,GPCR19) 和法尼酯X受体 (FXR) 在内的胆汁酸激活受体相互作用,可用于多种肝脏和胃肠道疾病的研究。此外,Ursodeoxycholic acid具有口服活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
| 产品描述 | Ursodeoxycholic acid-d5 is the deuterated form of Ursodeoxycholic acid. Ursodeoxycholic acid (Ursodeoxycholate) is a secondary bile acid produced through the transformation of (cheno)deoxycholic acid by intestinal bacteria. It plays a crucial role in maintaining intestinal barrier integrity and is essential for lipid metabolism. As a signaling molecule, Ursodeoxycholic acid functions by interacting with bile acid-activated receptors, including the G protein-coupled bile acid receptor 5 (TGR5, GPCR19) and the Farnesoid X receptor (FXR). It is used in research related to various liver and gastrointestinal disorders and is effective when administered orally. |
| 分子量 | 397.60 |
| 分子式 | C24H40O4 |
| CAS No. | 93701-18-9 |
| Smiles | C[C@@]12[C@]([C@]3([C@@]([C@]4(C)[C@](C[C@@H]3O)(C([C@](O)(C(C4)([2H])[2H])[2H])([2H])[2H])[H])(CC1)[H])[H])(CC[C@@]2([C@@H](CCC(O)=O)C)[H])[H] |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多